Skip to main content

Featured

Trump’s Oct. 30 Tariff Swap: Who Wins, Who Loses, and What It Means for Your Wallet

  Canadian Money Brief • October 27, 2026 Washington just reshuffled the 50% tariffs on Canadian goods. Seaweed and packing boxes are out. Vinyl flooring, cocoa powder and shampoo are in. Here is who comes out ahead, who doesn't, and what to do with your money before the changes take effect on Oct. 30. The short version This is a reshuffle, not a rollback: more products are going onto the 50% list than coming off it, according to a KPMG Law trade lawyer. Politics is the driver. The exemptions followed U.S. Sen. Susan Collins' push, 10 days before the U.S. midterms. Canada's own counter-tariffs, which affect prices in your store, are not changing. A broad trade deal before the midterms looks unlikely. What's coming off, what's going on The White House changes take effect at the end of this month. Reports from CTV News and Money.ca describe the swap this way: Coming off the 50% list Going onto the 50% list Seaweed Packing boxes Some plywood sheets Certain paper and pl...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment